Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 47
Filter
1.
Crit Rev Food Sci Nutr ; 63(32): 10995-11009, 2023.
Article in English | MEDLINE | ID: mdl-35730201

ABSTRACT

Enological evaluations capture the chemical and sensory space of wine using different techniques; many sensory methods as well as a variety of analytical chemistry techniques contribute to the amount of information generated. Data fusion, especially integrating data sets, is important when working with complex systems. The success reported when trying to integrate different modalities is generally low and has been attributed to the lack of statistically considerate strategies focusing on the data handling process. Multiple stages of data handling must be carefully considered when dealing with multi-modal data. In this review, the different stages in the data analysis process were examined. The study revealed misconceptions surrounding the process and elucidated rules for purpose-driven approaches by examining the complexities of each stage and the impact the decisions made at each stage have on the resulting models. The two major modeling approaches are either supervised (discrimination, classification, prediction) or unsupervised (exploration). Supervised approaches were emphatic on the pre-processing steps and prioritized increasing performance. Unsupervised approaches were mostly used for preliminary steps. The review found aspects often neglected when it came to the data collection and capturing which in the end contributed to the low success in combining sensory and chemistry data.


Subject(s)
Chemometrics , Wine
2.
Biomed Chromatogr ; 32(1)2018 Jan.
Article in English | MEDLINE | ID: mdl-29143970

ABSTRACT

Quality of the analytical data obtained for large-scale and long term bioanalytical studies based on liquid chromatography depends on a number of experimental factors including the choice of sample preparation method. This review discusses this tedious part of bioanalytical studies, applied to large-scale samples and using liquid chromatography coupled with different detector types as core analytical technique. The main sample preparation methods included in this paper are protein precipitation, liquid-liquid extraction, solid-phase extraction, derivatization and their versions. They are discussed by analytical performances, fields of applications, advantages and disadvantages. The cited literature covers mainly the analytical achievements during the last decade, although several previous papers became more valuable in time and they are included in this review.


Subject(s)
Analytic Sample Preparation Methods/methods , Biocompatible Materials/chemistry , Chromatography, Liquid/methods , Animals , Fractional Precipitation/methods , Humans , Liquid-Liquid Extraction/methods , Pharmaceutical Preparations/chemistry , Solid Phase Extraction/methods
3.
Expert Opin Drug Metab Toxicol ; 12(7): 743-52, 2016 Jul.
Article in English | MEDLINE | ID: mdl-27144662

ABSTRACT

INTRODUCTION: The absorption, distribution, metabolism, excretion and toxicity (ADME(T)) of oxime reactivators have been assessed with respect to their polarity, a fundamental requirement for their specific mechanism of action in the intoxication with organophosphorous compounds. The limitations of the therapeutic outcome have been associated not only with the severity of intoxication and to particularities of the toxicants, but also to the reduced lipophilicity and consequent restricted permeability across biological barriers. AREAS COVERED: This article inventories the plethora of mnemotic rules developed throughout the years for defining chemical spaces where drugs share one or more structural and ADME(T) characteristics. Their applicability to oxime is analyzed, especially in relation to intestinal absorption and brain distribution. Other aspects of oximes for antidotal outcome are also reviewed. EXPERT OPINION: The drugability rules are not applicable to oxime reactivators, because the increase in lipophicity and consequent improved permeability across biological barrier comes together with amplified (neuro)toxicity and reduced reactivating capacity. The available data suggest a high solubility and reduced metabolism, assigning the quaternary oximes to the fourth class of Biopharmaceutical Classification Systems. Reliance upon oral absorption data for designing safe centrally acting oximes can be of potential value, with adequate characterization of uptake-influx transporters interplay.


Subject(s)
Antidotes/administration & dosage , Organophosphate Poisoning/drug therapy , Oximes/administration & dosage , Animals , Antidotes/chemistry , Antidotes/pharmacokinetics , Brain/metabolism , Cholinesterase Reactivators/administration & dosage , Cholinesterase Reactivators/chemistry , Cholinesterase Reactivators/pharmacokinetics , Drug Design , Humans , Oximes/chemistry , Oximes/pharmacokinetics , Permeability , Solubility , Tissue Distribution
4.
J Chromatogr Sci ; 53(10): 1701-7, 2015.
Article in English | MEDLINE | ID: mdl-26115951

ABSTRACT

Appropriate substitution of acetonitrile (ACN) in mobile phases for reversed-phase liquid chromatography (RPLC) by low toxicity, ecologically friendly alternative solvents emerges as a greener approach in separation sciences. Ethyl lactate is considered as a green solvent in organic synthesis, industrial extraction processes and many other applicative fields. Its ability to substitute ACN in mobile phases for RPLC applications was barely investigated. The feasibility of such a replacement was tested for the separation of the mixture of 16 polycyclic aromatic hydrocarbons listed by the Environmental Protection Agency. The analytical approach was found to be achievable, with some compromises in terms of elution order, peak efficiency and UV detectability. Thermodynamic aspects of the chromatographic process were also comparatively assessed. Correlations between the elution order and some molecular descriptors were also discussed.

5.
Expert Opin Drug Metab Toxicol ; 11(1): 95-109, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25373357

ABSTRACT

INTRODUCTION: The therapeutic outcome of oximes used as reactivators of phosphorylated human acetylcholinesterase (AChE) is influenced, among other factors, by their biological distribution, their in vivo ability to achieve the nucleophilic attack and their affinity for the anionic center of the intact/inhibited AChE. AREAS COVERED: An in silico evaluation of the molecular descriptors and biopharmaceutical properties of 454 set of oximes has been achieved. The available pharmacokinetic (PK) data was analyzed, in an attempt to illustrate their common characteristics and particularities. Based on the observed high water solubility and low permeability across biological barriers, we applied the officially adopted classification systems based on biopharmaceutical properties to identify the existing biopharmaceutical differences between the various oxime entities and to predict their in vivo fate. EXPERT OPINION: The structural differences of the organophosphorus compounds (OP) and the available oximes reactivators of OP-inhibited AChE generate distinct toxicokinetic or PK profiles. The tissue compartment specific distribution is one of the key elements for assessment of reactivating efficiency. The distribution through highly specialized barriers, such as blood-brain barrier remains a considerable challenge. The high solubility - low permeability biopharmaceutical profile of oximes can be used to suggest the possible involvement of active transport systems.


Subject(s)
Acetylcholinesterase/metabolism , Antidotes/pharmacokinetics , Biopharmaceutics/classification , Cholinesterase Reactivators/pharmacokinetics , Oximes/pharmacokinetics , Animals , Antidotes/chemistry , Biopharmaceutics/methods , Cholinesterase Reactivators/chemistry , Humans , Oximes/chemistry , Structure-Activity Relationship , Treatment Outcome
6.
Talanta ; 122: 172-9, 2014 May.
Article in English | MEDLINE | ID: mdl-24720980

ABSTRACT

The liquid chromatographic behavior observed under bimodal retention conditions (reversed phase and hydrophilic interaction) offers a new basis for the determination of some derived lipophilicity indices. The experiments were carried out on a representative group (30 compounds) of pyridinium oximes, therapeutically tested in acetylcholinesterase reactivation, covering a large range of lipophilic character. The chromatographic behavior was observed on a mixed mode acting stationary phase, resulting from covalent functionalization of high purity spherical silica with long chain alkyl groups terminated by a polar environment created through the vicinal diol substitution at the lasting carbon atoms (Acclaim Mixed Mode HILIC 1 column). Elution was achieved by combining different proportions of 5 mM ammonium formiate solutions in water and acetonitrile. The derived lipophilicity indices were compared with logP values resulting from different computational algorithms. The correlations between experimental and computed data sets are significant. To obtain a better insight on the transition from reversed phase to hydrophilic interaction retention mechanisms, the variation of the thermodynamic parameters determined through the van׳t Hoff approach was also discussed.

7.
Talanta ; 119: 524-32, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24401451

ABSTRACT

AIM: Discrimination power evaluation of UV-Vis and (±) electrospray ionization/mass spectrometric techniques, (ESI-MS) individually considered or coupled as detectors to reversed phase liquid chromatography (RPLC) in the characterization of Ginkgo Biloba standardized extracts, is used in herbal medicines and/or dietary supplements with the help of Fuzzy hierarchical clustering (FHC). EXPERIMENTAL: Seventeen batches of Ginkgo Biloba commercially available standardized extracts from seven manufacturers were measured during experiments. All extracts were within the criteria of the official monograph dedicated to dried refined and quantified Ginkgo extracts, in the European Pharmacopoeia. UV-Vis and (±) ESI-MS spectra of the bulk standardized extracts in methanol were acquired. Additionally, an RPLC separation based on a simple gradient elution profile was applied to the standardized extracts. Detection was made through monitoring UV absorption at 220 nm wavelength or the total ion current (TIC) produced through (±) ESI-MS analysis. FHC was applied to raw, centered and scaled data sets, for evaluating the discrimination power of the method with respect to the origins of the extracts and to the batch to batch variability. RESULTS: The discrimination power increases with the increase of the intrinsic selectivity of the spectral technique being used: UV-Vis

Subject(s)
Chromatography, Reverse-Phase/methods , Fuzzy Logic , Ginkgo biloba/chemistry , Plant Extracts/standards , Spectrometry, Mass, Electrospray Ionization/methods , Spectrophotometry, Ultraviolet/methods , Cluster Analysis
8.
Bioanalysis ; 5(24): 3051-61, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24320130

ABSTRACT

The problem of sample diluent in bioanalytical LC-MS is reviewed with a special focus on large-volume injections and non-miscible solvents with mobile phase components. These issues are related to the sample preparation approach, which in many instances provides the sample diluent before injecting this into the chromatographic column. The sample volume influences the quantitation limit of the chromatographic method, while its nature may influence the retention process of the injected analytes. The literature reports a few papers that are focused on alternative sample diluents in bioanalytical LC-MS that are generally non-miscible with mobile phase. The principle of this approach and some of its current bioanalytical applications from literature are discussed. However, more applications and more publications from HPLC users and vendors are expected in this field, which could prove its analytical importance and potential in bioanalysis.


Subject(s)
Chromatography, High Pressure Liquid/methods , Mass Spectrometry/methods , Animals , Biochemistry/methods , Green Chemistry Technology/methods , Humans , Solvents/chemistry
9.
Expert Opin Drug Metab Toxicol ; 9(8): 955-68, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23600946

ABSTRACT

INTRODUCTION: The altered profiles of prolactin secretion in the anterior hypophysis, generated by pathological, pharmacological or toxicological causes, have special consequences on multiple functions in both genders. AREAS COVERED: This selective review presents the main mechanisms controlling prolactin secretion, focusing on the interplay of various neurotransmitters or xenobiotics, but also on the role of psychic or posttraumatic stress. A detailed analysis of several pharmacotherapeutic groups with hyperprolactinemic effects emphasize on the relevance of the pharmacokinetic/pharmacodynamic mechanisms and the clinical significance of the long term administration. EXPERT OPINION: Accurate monitoring and evaluation of the hyperprolactinemia induced by xenobiotics is strongly recommended. The typical antipsychotics and some of the atypical agents (amisulpride, risperidone, paliperidone), as well as some antidepressants, antihypertensives and prokinetics, are the most important groups inducing hyperprolactinemia. The hyperprolactinemic effects are correlated with their affinity for dopamine D2 receptors, their blood-brain barrier penetration and, implicitly, the requested dose for adequate occupancy of cerebral D2 receptors. Consequently, integration of available pharmacokinetic and pharmacodynamic data supports the idea of therapeutic switch to non-hyperprolactinemic agents (especially aripiprazole) or their association, for an optimal management of antipsychotic-induced hyperprolactinemia. Possible alternative strategies for counteracting the xenobiotics-induced hyperprolactinemia are also mentioned.


Subject(s)
Antipsychotic Agents/adverse effects , Hyperprolactinemia/chemically induced , Prolactin/metabolism , Xenobiotics/adverse effects , Amisulpride , Antipsychotic Agents/pharmacokinetics , Aripiprazole , Blood-Brain Barrier/metabolism , Humans , Hyperprolactinemia/pathology , Isoxazoles/adverse effects , Isoxazoles/pharmacokinetics , Paliperidone Palmitate , Piperazines/adverse effects , Piperazines/pharmacokinetics , Prolactin/antagonists & inhibitors , Pyrimidines/adverse effects , Pyrimidines/pharmacokinetics , Quinolones/adverse effects , Quinolones/pharmacokinetics , Receptors, Dopamine D2/metabolism , Risperidone/adverse effects , Risperidone/pharmacokinetics , Stress, Psychological , Sulpiride/adverse effects , Sulpiride/analogs & derivatives , Sulpiride/pharmacokinetics , Xenobiotics/pharmacokinetics
10.
Bioanalysis ; 5(7): 793-809, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23534424

ABSTRACT

BACKGROUND: Extreme efforts are made for the structural diversification of oximes used as AChE reactivators. Co-administration of different oximes should also be considered as a solution in therapy. Consequently, development of selective assays of oximes in biological matrices is of major importance. RESULTS: Three chromatographic separation mechanisms were evaluated: hydrophilic-interaction LC; mixed reversed-phase/cation exchange (DUET); and reversed-phase ion pairing based on per-fluorinated agents. MS was used to identify and quantify oximes. Alternative preparation of whole blood and plasma samples were used based on protein precipitation through addition of acetonitrile or ionic liquids. Quality characteristics of the proposed analytical approaches are discussed. CONCLUSION: The reversed-phase ion pairing based on per-fluorinated agents chromatographic separation mechanism and positive ESI-MS/MS detection produced the best results for the assay of bis-quaternary pyridinium oximes. LLOQ in the tenths of nanogram per milliliter range are achievable.


Subject(s)
Cholinesterase Reactivators/chemistry , Chromatography, Liquid/methods , Oximes/blood , Oximes/chemistry , Pyridinium Compounds/blood , Pyridinium Compounds/chemistry , Tandem Mass Spectrometry/methods , Acetylcholinesterase/chemistry , Humans
11.
J Pharm Biomed Anal ; 75: 1-6, 2013 Mar 05.
Article in English | MEDLINE | ID: mdl-23312378

ABSTRACT

Dimethyl sulfate (DMS) is frequently used in pharmaceutical manufacturing processes as an alkylating agent. Trace levels of DMS in drug substances should be carefully monitored since the compound can become an impurity which is genotoxic in nature. Derivatization of DMS with dibenzazepine leads to formation of the N-methyl derivative, which can be retained on a reversed phase column and subsequently separated from other potential impurities. Such derivatization occurs relatively slowly. However, it can be substantially speed up if ionic liquids are used as reaction media. In this paper we report the use of 1-butyl-1-methylpyrrolidinium bis(trifluoromethylsulfonyl)imide (IL1) and 1-butyl-4-methylpyridinium tetrafluoroborate (IL2) as reaction media for the derivatization of DMS with dibenzazepine. It was determined that the stoichiometry between the substrate and DMS may be 1:1 or 2:1, in relation with the nature of the reaction media. An (+)ESI-MS/MS approach was used for quantitation of the derivatized product. Alternatively, DMS derivatization may be carried out with pyridine in acetonitrile (ACN). The N-methylpyridinium derivative was separated by hydrophilic interaction liquid chromatography (HILIC) and detected through (+)ESI-MS (in the SIM mode). In both cases, a limit of quantitation (LOQ) of 0.05 µg/ml DMS was achievable, with a linearity range up to 10 µg/ml. Both analytical alternatives were applied to assay DMS in 4-(2-methoxyethyl)phenol, which is used as a starting material in the synthesis of metoprolol.


Subject(s)
Alkylating Agents/analysis , Mutagens/analysis , Sulfuric Acid Esters/analysis , Acetonitriles/chemistry , Alkylating Agents/chemistry , Analytic Sample Preparation Methods , Borates/chemistry , Chemistry, Pharmaceutical , Chromatography, High Pressure Liquid , Chromatography, Reverse-Phase , Dibenzazepines/chemistry , Drug Contamination/prevention & control , Hydrophobic and Hydrophilic Interactions , Imides/chemistry , Indicators and Reagents/chemistry , Ionic Liquids/chemistry , Kinetics , Limit of Detection , Mutagens/chemistry , Pyridines/chemistry , Pyridinium Compounds/chemistry , Pyrrolidines/chemistry , Spectrometry, Mass, Electrospray Ionization , Sulfuric Acid Esters/chemistry , Tandem Mass Spectrometry
12.
J Pharm Biomed Anal ; 75: 230-8, 2013 Mar 05.
Article in English | MEDLINE | ID: mdl-23277155

ABSTRACT

Substitution of acetonitrile (ACN) as organic modifier in mobile phases for liquid chromatography by mixtures of propylene carbonate (PC) and ethanol (EtOH) may be considered a greener approach for pharmaceutical applications. Such a replacement is achievable without any major compromise in terms of elution order, chromatographic retention, efficiency and peak symmetry. This has been equally demonstrated for reverse phase (RP), ion pair formation (IP) and hydrophilic interaction liquid chromatography (HILIC) separation modes. The impact on the sensitivity induced by the replacement between these organic solvents is discussed for UV-vis and mass spectrometric detection. A comparison between Van Deemter plots obtained under elution conditions based on ACN and PC/EtOH is presented. The alternative elution modes were also compared in terms of thermodynamic parameters, such as standard enthalpy (ΔH°) and entropic contributions to the partition between the mobile and the stationary phases, for some model compounds. Van't Hoff plots demonstrated that differences between the thermodynamic parameters are minor when shifting from ACN/water to PC/EtOH/water elution on an octadecyl chemically modified silicagel stationary phase. As long as large volume injection (LVI) of diluents non-miscible with the mobile phase is a recently developed topic having a high potential of greening the sample preparation procedures through elimination of the solvent evaporation stage, this feature was also assessed in the case of ACN replacement by PC/EtOH.


Subject(s)
Ethanol/chemistry , Green Chemistry Technology , Pharmaceutical Preparations/analysis , Propane/analogs & derivatives , Solvents/chemistry , Acetonitriles/chemistry , Acetonitriles/toxicity , Chemistry, Pharmaceutical , Chromatography, High Pressure Liquid , Ethanol/toxicity , Feasibility Studies , Limit of Detection , Pharmaceutical Preparations/chemistry , Propane/chemistry , Propane/toxicity , Solubility , Solvents/toxicity , Spectrometry, Mass, Electrospray Ionization , Spectrophotometry , Tandem Mass Spectrometry , Thermodynamics
13.
Article in English | MEDLINE | ID: mdl-23266124

ABSTRACT

Green bioanalytical approaches are oriented toward minimization or elimination of hazardous chemicals associated to bioanalytical applications. LC/MS-MS assay of enalapril and enalaprilat in human plasma was achieved by elimination of acetonitrile from both sample preparation and chromatographic separation stages. Protein precipitation (PP) by acetonitrile addition was replaced by liquid-liquid extraction (LLE) in 1-octanol followed by direct large volume injection of the organic layer in the chromatographic column operated under reversed phase (RP) separation mechanism. At the mean time, acetonitrile used as organic modifier in the mobile phase was successfully replaced by a mixture of propylene carbonate/ethanol (7/3, v/v). Three analytical alternatives ((I) acetonitrile PP+acetonitrile based chromatographic elution; (II) 1-octanol LLE+acetonitrile based chromatographic elution; (III) 1-octanol LLE+propylene carbonate/ethanol based chromatographic elution) were validated and the quality characteristics were compared. Comparison between these alternative analytical approaches was also based on results obtained on incurred samples taken during a bioequivalence study, through application of the Bland-Altman procedure.


Subject(s)
Chromatography, Liquid/methods , Enalapril/blood , Enalaprilat/blood , Green Chemistry Technology/methods , Tandem Mass Spectrometry/methods , 1-Octanol/chemistry , Acetonitriles/chemistry , Cross-Over Studies , Enalapril/chemistry , Enalapril/isolation & purification , Enalaprilat/chemistry , Enalaprilat/isolation & purification , Ethanol/chemistry , Humans , Linear Models , Liquid-Liquid Extraction , Propane/analogs & derivatives , Propane/chemistry , Randomized Controlled Trials as Topic , Reproducibility of Results , Sensitivity and Specificity , Therapeutic Equivalency , Water/chemistry
14.
Expert Opin Drug Metab Toxicol ; 9(1): 31-50, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23176543

ABSTRACT

INTRODUCTION: The more or less systematic studies on the specific activity of oximes as reactivators of acetylcholinesterase (AChE) inhibited by organophosphorus (OP) compounds provide a panoramic image of their pharmacological and toxicological profiles. Established structure-activity relationships are still unable to adequately predict their antidotal efficacy. However, the in vivo behavior of oximes is a direct consequence of their physico-chemical properties, considerably limiting the passive transport across the biological barriers. AREAS COVERED: This paper discusses the efficacy of oximes from a biokinetic perspective. The non-homogenous distribution of oximes versus OP in tissues was considered and correlated with the highly variable AChE reactivation at both peripheral and central levels. The acute toxicity and formation of highly toxic phosphylated oximes are presented as possible sources for reduced therapeutic efficacy. EXPERT OPINION: Biokinetic of oximes is 'structure dependent', with variable, tissue-specific distribution and activity. The existing knowledge does not allow to state true limits for a minimum extent of AChE reactivation in different tissues granting the survival of intoxicated organisms. An increased penetration of biological barriers is not automatically equivalent to a high extent of reactivation or antidotal efficacy and most probably, induces significant risks because of the intrinsic toxicity of the oxime.


Subject(s)
Acetylcholinesterase/metabolism , Cholinesterase Reactivators/adverse effects , Oximes/adverse effects , Animals , Cholinesterase Reactivators/chemistry , Humans , Oximes/chemistry , Structure-Activity Relationship , Tissue Distribution/drug effects , Tissue Distribution/physiology
15.
Biomed Chromatogr ; 27(1): 48-57, 2013 Jan.
Article in English | MEDLINE | ID: mdl-22511331

ABSTRACT

Limonene, considered a green solvent, was successfully used to extract simvastatin, lovastatin, and their hydroxy-acid metabolites from human plasma samples. The extraction process was followed by the direct injection of a large volume aliquot (100 µL) from the limonene layer into a Zorbax SB-C(18) Rapid Resolution chromatographic column (50 mm length × 4.6 mm i.d. × 1.8 µm d.p.), operated under gradient elution reversed-phase separation mechanism. Tandem mass spectrometry operated under the multiple reaction monitoring mode was used for detection, providing low quantitation limits in the 0.25-0.5 ng/mL concentration interval. This method was validated and used for quantitation of simvastatin and its hydroxy acid metabolite in incurred plasma samples obtained from two volunteers participating in a bioequivalence study, using lovastatin and its hydroxy analog as internal standards. The results were statistically compared with those produced by means of an alternative RPLC-tandem MS using protein precipitation with acetonitrile. The quality attributes of the two methods are comparatively discussed. The agreement between the quality characteristics of the two methods and the experimental results obtained on real samples may be considered as a consistent basis for the simultaneous use of limonene as extraction medium and injection diluent for hydrophobic compounds in bioanalytical approaches.


Subject(s)
Chromatography, Reverse-Phase/methods , Cyclohexenes/chemistry , Green Chemistry Technology/methods , Hydroxymethylglutaryl-CoA Reductase Inhibitors/blood , Tandem Mass Spectrometry/methods , Terpenes/chemistry , Cross-Over Studies , Fasting/blood , Female , Humans , Limonene , Male , Refractometry , Regression Analysis , Reproducibility of Results , Solvents/chemistry
16.
Biomed Chromatogr ; 26(2): 208-13, 2012 Feb.
Article in English | MEDLINE | ID: mdl-21567434

ABSTRACT

Calibration data of LC-MS/MS rarely fit the pure least square regression model, especially for large concentration intervals. The response function of the MS instrument is corrected by weighted regression models or logarithms. The choice of a response linearization method is based on results produced through back-interpolation of experimental data and/or evaluation of correlation coefficients. Two bioequivalence studies carried out for pharmaceutical formulations containing metformin gave us the opportunity to appreciate the impact of the MS response linearization method (logarithm and 1/x weighted linear regression) on method quality characteristics. The sample preparation was based on protein precipitation with acetonitrile. Chromatographic separation was achieved on a Zorbax CN column (mobile phase acetonitrile and aqueous 10 m m ammonium acetate solution, pH 3.5). Tandem MS detection was performed on a triple quadrupole spectrometer equipped with an electrospray source, operated under positive-ion mode. The method was validated and used for evaluation of the bioequivalence of formulations containing 500 and 1000 mg metformin. The 500 mg metformin study used logarithms for linearization of the detector response, while the 1000 mg metformin study was based on 1/x linear weighted regression. Data resulting from validations and studies completion were compared with evaluate the impact of the response linearization on the method quality characteristics.


Subject(s)
Metformin/blood , Tandem Mass Spectrometry/methods , Chromatography, Liquid , Cross-Over Studies , Humans , Linear Models , Metformin/pharmacokinetics , Models, Statistical , Reproducibility of Results , Sensitivity and Specificity , Tandem Mass Spectrometry/standards , Therapeutic Equivalency
17.
Eur Neuropsychopharmacol ; 22(5): 319-29, 2012 May.
Article in English | MEDLINE | ID: mdl-21917428

ABSTRACT

The metabolic processes frequently trigger highly complex pharmacokinetic (PK) and pharmacodynamic (PD) characteristics for the coexisting entities, parent drug and its active or inactive metabolites. The interpretation of both individual and cumulative profiles, frequently used in the therapeutic drug monitoring procedures, must take into consideration the biological coherence of the changes of the molecular descriptors characterizing the metabolites versus the parent drugs, and further qualitative and quantitative consequences on permeability processes across highly specialized biological barriers (e.g. blood-brain barrier [BBB]). This paper analyzes the correlation of molecular descriptor differences and the PK/PD consequences for three representative psychotropic drugs (risperidone, clozapine and tramadol) and their active metabolites, underlying the safety and efficacy concerns of using the products of metabolic processes as potential new drugs. The minimal structural changes are correlated with the predicted or experimental penetrability across the biological membranes, with a special emphasis on BBB penetration, as the limiting phase for the effect at central nervous system level. The PD characteristics related to the active metabolites are compared to the ones reported for the parent drugs, concerning mainly the affinity for cerebral receptors and the type of activity at a specific level. For the neuropsychotropic substances, with BBB penetrability as a sine qua non condition, the comparative analysis of PK/PD properties for the parent drug and its metabolites generates a complete and highly complex image of the consequences of their coexistence, since these entities must be conceived and analyzed not separately, but by inclusion of usually complementary properties generating a unique therapeutic profile.


Subject(s)
Blood-Brain Barrier/metabolism , Psychotropic Drugs/pharmacokinetics , Animals , Biotransformation/drug effects , Biotransformation/physiology , Blood-Brain Barrier/drug effects , Humans , Permeability/drug effects , Psychotropic Drugs/pharmacology , Tissue Distribution/drug effects , Tissue Distribution/physiology
18.
J Pharm Biomed Anal ; 57: 82-93, 2012 Jan 05.
Article in English | MEDLINE | ID: mdl-21945453

ABSTRACT

The retention behavior of some flavonoids in reversed phase liquid chromatography (RPLC) was investigated using different chemistries of the modified silicagel based stationary phases. Highly end-capped octadecyl silicagel (ODS), polar embedded linker octadecyl silicagel (SB-18 Aqua), phenyl silicagel and pentafluorophenyl modified silicagel (PFP) were used as stationary phases. The mobile phase consisted in acetonitrile/acidified water mixtures, at different fractions of volume. The lipophilicity was estimated through different chromatographic descriptors, as it follows: log k(w), m log k, S, φ(0) and PC1/log k. The chromatographic behavior observed on the mentioned stationary phases was evaluated by means of various graphical profiles and correlation matrices. Additionally, new information about the characteristics of the stationary phases and their (dis)-similarities were provided through lipophilicity charts and by scatterplots of loadings obtained by applying principal component analysis (PCA) to retention data. Furthermore, the experimental lipophilicity indices estimated from retention data were correlated with the computed descriptors, at a high level of statistical significance.


Subject(s)
Chromatography, Liquid/methods , Flavonoids/chemistry , Principal Component Analysis
19.
Bioanalysis ; 3(17): 1935-47, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21899503

ABSTRACT

BACKGROUND: Liquid-liquid extraction of target compounds from biological matrices followed by the injection of a large volume from the organic layer into the chromatographic column operated under reversed-phase (RP) conditions would successfully combine the selectivity and the straightforward character of the procedure in order to enhance sensitivity, compared with the usual approach of involving solvent evaporation and residue re-dissolution. Large-volume injection of samples in diluents that are not miscible with the mobile phase was recently introduced in chromatographic practice. The risk of random errors produced during the manipulation of samples is also substantially reduced. RESULTS: A bioanalytical method designed for the bioequivalence of fenspiride containing pharmaceutical formulations was based on a sample preparation procedure involving extraction of the target analyte and the internal standard (trimetazidine) from alkalinized plasma samples in 1-octanol. A volume of 75 µl from the octanol layer was directly injected on a Zorbax SB C18 Rapid Resolution, 50 mm length × 4.6 mm internal diameter × 1.8 µm particle size column, with the RP separation being carried out under gradient elution conditions. Detection was made through positive ESI and MS/MS. Aspects related to method development and validation are discussed. CONCLUSIONS: The bioanalytical method was successfully applied to assess bioequivalence of a modified release pharmaceutical formulation containing 80 mg fenspiride hydrochloride during two different studies carried out as single-dose administration under fasting and fed conditions (four arms), and multiple doses administration, respectively. The quality attributes assigned to the bioanalytical method, as resulting from its application to the bioequivalence studies, are highlighted and fully demonstrate that sample preparation based on large-volume injection of immiscible diluents has an increased potential for application in bioanalysis.


Subject(s)
Chromatography, High Pressure Liquid/methods , Mass Spectrometry/methods , Spiro Compounds/analysis , Spiro Compounds/pharmacokinetics , Chromatography, High Pressure Liquid/instrumentation , Mass Spectrometry/instrumentation , Reproducibility of Results , Therapeutic Equivalency
20.
Bioanalysis ; 3(12): 1343-56, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21679029

ABSTRACT

BACKGROUND: The inherent reproducibility of a bioanalytical approach is usually sustained through incurred sample reanalysis (ISR). Questions relating to the number of ISRs, the right moment for performing reanalysis, the way of performing an appropriate statistical refinement of experimental data and actions to be taken in the case of failure are frequently raised. RESULTS: Data resulting from ISR following a bioequivalence study for spironolactone formulations are discussed. Reanalysis of samples was carried out twice: immediately after the end of the study and after a period that overcame the long-term stability study achieved during method validation. The Bland-Altman approach was used to assess experimental results. ISR was successful over the short reanalysis period for both compounds. Data produced through reanalysis after the long-term period indicated a systematic positive bias for the metabolite canrenone (although results supported reproducibility). The results obtained for spironolactone were affected by a strong negative systematic bias and failed to support reproducibility. The explanation deals with the continuous conversion of spironolactone to canrenone in plasma samples. However, reproducibility of the method may be sustained by comparing original and repeated differences between concentration values in samples by means of a paired t-test, Wilcoxon sign rank-sum test and linear regression. CONCLUSIONS: Different statistical approaches for making data comparisons are discussed and may be successfully applied during reanalysis of samples from a bioequivalence study. Results of the evaluations may differ in accordance with the statistical procedure being applied, thus a definitive conclusion requires consideration of all specific experimental circumstances arising during production of the processed data.


Subject(s)
Canrenone/blood , Spironolactone/blood , Female , Humans , Male , Reproducibility of Results , Spironolactone/metabolism , Therapeutic Equivalency
SELECTION OF CITATIONS
SEARCH DETAIL
...